Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

Similar articles for PubMed (Select 24361612)

1.

Allosteric modulators of human A2B adenosine receptor.

Trincavelli ML, Giacomelli C, Daniele S, Taliani S, Cosimelli B, Laneri S, Severi E, Barresi E, Pugliesi I, Greco G, Novellino E, Da Settimo F, Martini C.

Biochim Biophys Acta. 2014 Mar;1840(3):1194-203. doi: 10.1016/j.bbagen.2013.12.021. Epub 2013 Dec 19.

PMID:
24361612
2.

Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives.

Taliani S, Trincavelli ML, Cosimelli B, Laneri S, Severi E, Barresi E, Pugliesi I, Daniele S, Giacomelli C, Greco G, Novellino E, Martini C, Da Settimo F.

Eur J Med Chem. 2013 Nov;69:331-7. doi: 10.1016/j.ejmech.2013.09.001. Epub 2013 Sep 8.

PMID:
24077183
3.

Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA.

J Med Chem. 2004 Mar 11;47(6):1434-47.

PMID:
14998332
4.

Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.

Baraldi PG, Cacciari B, Pineda de Las Infantas MJ, Romagnoli R, Spalluto G, Volpini R, Costanzi S, Vittori S, Cristalli G, Melman N, Park KS, Ji XD, Jacobson KA.

J Med Chem. 1998 Aug 13;41(17):3174-85.

PMID:
9703463
5.

A(2b) receptor mediates adenosine inhibition of taurine efflux from pituicytes.

Pierson PM, Peteri-Brunbäck B, Pisani DF, Abbracchio MP, Mienville JM, Rosso L.

Biol Cell. 2007 Aug;99(8):445-54.

PMID:
17391106
6.

Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.

Gao ZG, Ye K, Göblyös A, Ijzerman AP, Jacobson KA.

BMC Pharmacol. 2008 Dec 12;8:20. doi: 10.1186/1471-2210-8-20.

7.

Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.

Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9.

PMID:
9459566
8.

Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.

Trincavelli ML, Marroni M, Tuscano D, Ceruti S, Mazzola A, Mitro N, Abbracchio MP, Martini C.

J Neurochem. 2004 Dec;91(5):1180-90.

PMID:
15569261
9.

Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.

Phelps PT, Anthes JC, Correll CC.

Eur J Pharmacol. 2006 Apr 24;536(1-2):28-37. Epub 2006 Mar 3.

PMID:
16581066
11.

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

Kim YC, de Zwart M, Chang L, Moro S, von Frijtag Drabbe Künzel JK, Melman N, IJzerman AP, Jacobson KA.

J Med Chem. 1998 Jul 16;41(15):2835-45.

PMID:
9667972
12.

A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils.

van der Hoeven D, Wan TC, Gizewski ET, Kreckler LM, Maas JE, Van Orman J, Ravid K, Auchampach JA.

J Pharmacol Exp Ther. 2011 Sep;338(3):1004-12. doi: 10.1124/jpet.111.181792. Epub 2011 Jun 21.

13.

The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.

Zhang JG, Hepburn L, Cruz G, Borman RA, Clark KL.

Biochem Pharmacol. 2005 Mar 15;69(6):883-9.

PMID:
15748700
14.

Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.

Urmaliya VB, Church JE, Coupar IM, Rose'Meyer RB, Pouton CW, White PJ.

J Cardiovasc Pharmacol. 2009 May;53(5):424-33. doi: 10.1097/FJC.0b013e3181a443e2.

PMID:
19333129
15.

Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells.

Suh BC, Kim TD, Lee JU, Seong JK, Kim KT.

Br J Pharmacol. 2001 Sep;134(1):132-42.

16.

BAY60-6583 acts as a partial agonist at adenosine A2B receptors.

Hinz S, Lacher SK, Seibt BF, Müller CE.

J Pharmacol Exp Ther. 2014 Jun;349(3):427-36. doi: 10.1124/jpet.113.210849. Epub 2014 Mar 14.

PMID:
24633424
17.

Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.

Varani K, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Benini A, Klotz KN, Baraldi PG, Tabrizi MA, Lennan SM, Leung E, Borea PA.

Biochem Pharmacol. 2005 Nov 25;70(11):1601-12. Epub 2005 Oct 10.

PMID:
16219300
18.

A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.

Vittori S, Costanzi S, Lambertucci C, Portino FR, Taffi S, Volpini R, Klotz KN, Cristalli G.

Nucleosides Nucleotides Nucleic Acids. 2004;23(1-2):471-81.

PMID:
15043167
19.

Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.

Varani K, Caramori G, Vincenzi F, Tosi A, Barczyk A, Contoli M, Casolari P, Triggiani M, Hansel T, Leung E, Maclennan S, Barnes PJ, Chung KF, Adcock I, Papi A, Borea PA.

FASEB J. 2010 Apr;24(4):1192-204. doi: 10.1096/fj.09-139485. Epub 2009 Dec 14.

20.

Agonist-induced desensitization of A2B adenosine receptors.

Peters DM, Gies EK, Gelb CR, Peterfreund RA.

Biochem Pharmacol. 1998 Mar 15;55(6):873-82.

PMID:
9586960
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk